Research Labs

  • Focusing on genetic and molecular basis of antimalarial drug resistance in P. falciparum, antimalarial drug discovery, genetically attenuated parasite vaccines, parasite lipid metabolism.

  • Dr. Sobieszczyk’s major investigative interest is the treatment and prevention of HIV and SARS-CoV-2.

  • The Uhlemann Lab studies the evolution of drug resistance in bacteria and the relationship between intestinal microbiome and colonization with multi-drug resistant organisms.